QA: Abbvie Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2023_Abbvie_Inc.pdf

Logs

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 28,463,000,000
1 IntangibleAssetsNetIncludingGoodwill 99,595,000,000
2 PropertyPlantAndEquipmentNet 4,935,000,000
3 remainder_Assets 5,812,000,000
4 LiabilitiesCurrent 29,538,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 17,410,684,535
8 SellingGeneralAndAdministrativeExpense 16,328,595,586
9 ResearchAndDevelopmentExpense 7,417,382,431
10 remainder_Expenses 1,702,943,585
11 remainder_Revenues 58,915,546,912
12 remainder_NetIncome -4,641,915,617
13 remainder_ComprehensiveNetIncome 504,468,548
  yvar yval
0 Assets 138,805,000,000
1 Liabilities 29,538,000,000
2 Expenses 42,859,606,137
3 Revenues 58,915,546,912
4 StockholdersEquity 109,267,000,000
5 NetIncome 11,414,025,158
6 ComprehensiveNetIncome 11,666,259,432
7 BaseVar 137,632,268,607
8 EconomicCapitalRatiobeforeLimitedLiability 2.97
9 EconomicCapitalRatio 3.67

Edgar->Model Mapping

Feature Distribution

Change over Time